Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells
Xiaoli Wang, Wei Zhang, Joseph Tripodi, Min Lu, Mingjiang Xu, Vesna Najfeld, Yan Li, Ronald Hoffman
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells'. Together they form a unique fingerprint.